FDA Approved Products

190 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:All NDA BLA ANDA

Lifecycle:Growth Peak LOE Approaching Post-LOE Launch Pre-Launch

Sort:Approval Date Name Competitive Pressure↓

Active:Lifecycle: GrowthClear all

rizatriptan benzoate

Cipher Pharmaceuticals

ORAL · CAPSULE

imetelstat sodium

INTRAVENOUS · POWDER

more red blood cell units over 8 weeks

phentolamine mesylate

OPHTHALMIC · SOLUTION

sofpironium bromide

Botanix Pharmaceuticals

TOPICAL · GEL, METERED

ORAL · CAPSULE

polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution

ORAL · FOR SOLUTION

meloxicam, rizatriptan

Axsome Therapeutics

ORAL · CAPSULE

INTRAVENOUS · SOLUTION

ORAL · SOLUTION

TRIKAFTA (COPACKAGED)

elexacaftor, tezacaftor, and ivacaftor

Vertex Pharmaceuticals

ORAL · GRANULES

cystic fibrosis (CF) in patients aged 2 yearsolder+1

TRYNGOLZA (AUTOINJECTOR)

olezarsen sodium

Ionis Pharmaceuticals

SUBCUTANEOUS · SOLUTION

SUBCUTANEOUS · SUSPENSION, EXTENDED RELEASE

Akebia Therapeutics

combination with standard cytarabineanthracycline induction+3

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

vasopressin in 0.9% sodium chloride

INTRAVENOUS · SOLUTION

cyclosporine ophthalmic solution

OPHTHALMIC · SOLUTION

ORAL · SOLUTION

ORAL · GRANULES

older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS)

← PreviousPage 7 of 8Next →